Comparing Methods of Recall for Cancer Screening in Primary Care: a Pragmatic Clinical Trial

Cancer Clinical Trial

Official title:

Comparing Methods of Recall for Cancer Screening in Primary Care: a Pragmatic Randomized Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02457143
• Other study ID #: 15-145
• Status: Completed
• Phase: N/A
• First received: May 27, 2015
• Last updated: October 14, 2016
• Start date: July 2015
• Est. completion date: July 2016

Study information

• Verified date: October 2016
• Source: St. Michael's Hospital, Toronto
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Interventional

Clinical Trial Summary

This randomized trial aims to understand how effective a reminder letter is compared to a reminder phone call in improving breast, cervical and colorectal cancer screening rates and reducing screening disparities.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5270
• Est. completion date: July 2016
• Est. primary completion date: July 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 21 Years to 74 Years

Eligibility

Inclusion Criteria:

• The trial will include patients who are rostered to the family practice as of March 31, 2015, are eligible and overdue for cervical, breast and/or colorectal cancer screening and are verified by their primary care physician as needing recall.

Exclusion Criteria:

• Patients will be excluded if their primary care physician noted they should not be recalled for screening or if the patient does not have both an address and a phone number on file.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening

Related Conditions & MeSH terms

• Cancer
• Early Detection of Cancer
• Socioeconomic Status

Intervention

Behavioral:
• Letter

• Phone call

Locations

Country	Name	City	State
Canada	St. Michael's Hospital Academic Family Health Team	Toronto	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
St. Michael's Hospital, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The proportion of patients in each arm who go on to receive at least one screening test for which they are due		6 months	No
Primary	The proportion of patients in each arm who are due for breast, cervical and colorectal cancer screening who go on to receive those respective screening tests (female patients may be represented in the outcome calculation of more than one cancer screening		6 months	No